BeiGene Ltd.

(BGNE) Trade

By |

Profile

BeiGene Ltd is a clinical-stage biopharmaceutical company engaged in the discovery & development of molecularly targeted & immuno-oncology drugs for the treatment of cancer. Its product include BGB-3111, BGB-283 and BGB-290 and one immuno-oncology agent.

Contact Information

Website: www.beigene.com
Main Phone: +1 345 949-4123
Address: c/o Mourant Ozannes Corporate Services (Cayman) Limited
Address 2: 94 Solaris Avenue, Camana Bay, PO Box 1348
City / Town: Grand Cayman
Country: CYM
Postal Code: KY1-1108

Issuer Information

Exchange: NGS
Employees: 194
NAICS: Pharmaceutical P
$ 80.73 $ -3.3 (-3.93%)
Last Price 80.73 Change $ -3.3 Change % -3.93 Tick N/A
Bid 80.63 Bid Size 100.00 Ask 81.17 Ask Size 100.00
Open 84.37 High 85.07 Low 80.13 Prev Close 84.03
Last Trade Volume 160,248 52 Wk Hi 118.95 52 Wk Low 26.43
Market Cap 3.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 45,369,270.00 EPS (TTM) -5.07 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 44 44 44 44
Low Target Price Estimate 42 42 42 42
Mean Target Price Estimate 43 43 43 43
Standard Deviation 1.41 1.41 1.41 1.41
Date of Most Recent Estimate 08/11/16 07/11/16 07/11/16 08/11/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.17 1.17 1.17 1.17

News